S103
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for S103, covering 2025-05-06 to 2025-05-06. Get the full timeline:
Most recent: Clinical Trial Update: The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia Gravis [Phase 1]